Danilo Cimadomo

Danilo Cimadomo

G.EN.E.R.A. Centers for Reproductive Medicine

Affiliated withG.EN.E.R.A. Centers for Reproductive MedicineGeneraLife IVF

Research Area

Biography

Danilo Cimadomo is the Science and Research manager of GeneraLife IVF. He received his BSc and MSc degrees cum laude at the University of Pavia in “Medical Biotechnologies” and “Molecular Biology and Genetics”, respectively, and its PhD at the University of Rome “Sapienza” in “Morphogenesis and Tissue Engineering”. After two internships at the University of Pavia and at the University of Cambridge, he started working at the G.en.e.r.a. centers where he contributed to the validation, implementation, and monitoring of a qPCR-based aneuploidy testing strategy for blastocyst stage PGT. His research is focused on the strategies for embryo selection. He is Author or co-Author of more than 60 papers in peer-reviewed journals, book chapters, and several abstracts at Italian and international meetings. He is part of the Executive Committee of the Italian Society of embryology, reproduction, and research (SIERR). He is the Basic Science officer of the ESHRE SIG in implantation and early pregnancy. He is reviewer or associate editor of several journals in the field of reproductive medicine and embryology

JoVE Journal Publications

ArticleTotal : 2
Year
Human Blastocyst Biopsy and Vitrification
Publication title

Cited by 36

2019
2021

Other Publications

Article
Year
Failure mode and effects analysis of witnessing protocols for ensuring traceability during PGD/PGS cycles.

Reproductive biomedicine online| PubMed ID: 27372783

2016
Pre-implantation genetic testing in ART: who will benefit and what is the evidence?

Journal of assisted reproduction and genetics| PubMed ID: 27491771

2016
What is new in the management of poor ovarian response in IVF?

Current opinion in obstetrics & gynecology| PubMed ID: 29664789

2018
2018
2018
2018
2018
Impact of Maternal Age on Oocyte and Embryo Competence.

Frontiers in endocrinology| PubMed ID: 30008696

2018
2018
2018
2019
2019
2019
2020
2021
2021
2021
2021
2021
2021
Is a randomized controlled design sufficient for a trial to be valuable?

Human reproduction (Oxford, England)| PubMed ID: 33993295

2021
In vitro fertilization and andrology laboratories in 2030.

Fertility and sterility| PubMed ID: 34148585

2021
2021
2021
2021
2021